(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1347735 6480464 epigallocatechin gallate results in decreased expression of LGALS1 mRNA CTD PMID:35701726 (1->4)-beta-D-glucan multiple interactions ISO RGD:737568 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS1 mRNA CTD PMID:36331819 (S)-nicotine increases expression ISO RGD:1347735 6480464 Nicotine results in increased expression of LGALS1 mRNA CTD PMID:23825647 1,1-dichloroethene increases expression ISO RGD:737568 6480464 vinylidene chloride results in increased expression of LGALS1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of LGALS1 mRNA CTD PMID:27840820 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LGALS1 mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:737568 6480464 Ethinyl Estradiol affects the expression of LGALS1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of LGALS1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:737568 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LGALS1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:737568 6480464 Ethinyl Estradiol results in increased expression of LGALS1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1347735 6480464 Estradiol results in decreased expression of LGALS1 mRNA CTD PMID:23019147 , PMID:31646340 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LGALS1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO RGD:1347735 6480464 Estradiol inhibits the reaction [Fulvestrant results in increased expression of LGALS1 mRNA] CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:1347735 6480464 Estradiol results in increased expression of LGALS1 mRNA CTD PMID:23373633 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1347735 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737568 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LGALS1 mRNA more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737568 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS1 mRNA CTD PMID:26290441 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737568 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS1 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1347735 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS1 mRNA CTD PMID:22298810 , PMID:34747641 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1347735 6480464 2 more ... CTD PMID:17547211 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of LGALS1 protein CTD PMID:19079321 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737568 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mRNA] CTD PMID:16054899 3-methyladenine multiple interactions ISO RGD:1347735 6480464 3-methyladenine inhibits the reaction [LGALS1 protein results in decreased expression of SQSTM1 protein] more ... CTD PMID:30365942 3-methylcholanthrene increases expression ISO RGD:1347735 6480464 Methylcholanthrene results in increased expression of LGALS1 mRNA CTD PMID:22579512 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LGALS1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane affects expression ISO RGD:737568 6480464 4, 4'-diaminodiphenylmethane affects the expression of LGALS1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:737568 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LGALS1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO RGD:1347735 6480464 Decitabine affects the expression of LGALS1 mRNA CTD PMID:23300844 8-Br-cAMP decreases expression ISO RGD:1347735 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LGALS1 mRNA CTD PMID:22079614 acetohydrazide increases expression ISO RGD:737568 6480464 acetylhydrazine results in increased expression of LGALS1 mRNA CTD PMID:15282401 aflatoxin B1 affects expression ISO RGD:1347735 6480464 Aflatoxin B1 affects the expression of LGALS1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:737568 6480464 Aflatoxin B1 results in increased expression of LGALS1 mRNA CTD PMID:19770486 alachlor increases expression EXP 6480464 alachlor results in increased expression of LGALS1 mRNA CTD PMID:12419858 all-trans-retinoic acid decreases expression ISO RGD:1347735 6480464 Tretinoin results in decreased expression of LGALS1 mRNA CTD PMID:17218384 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:737568 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LGALS1 mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:1347735 6480464 Tretinoin results in increased expression of LGALS1 mRNA CTD PMID:15498508 amitrole increases expression EXP 6480464 Amitrole results in increased expression of LGALS1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LGALS1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1347735 6480464 Antirheumatic Agents results in increased expression of LGALS1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1347735 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of LGALS1 mRNA CTD PMID:16934159 arsenite(3-) decreases expression ISO RGD:1347735 6480464 arsenite results in decreased expression of LGALS1 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:1347735 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of LGALS1 mRNA], arsenite promotes the reaction [G3BP1 protein binds to LGALS1 protein] CTD PMID:31646340 , PMID:32406909 arsenous acid decreases secretion ISO RGD:737568 6480464 LGALS1 protein results in decreased secretion of Arsenic Trioxide CTD PMID:21596116 arsenous acid increases response to substance ISO RGD:737568 6480464 LGALS1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:21596116 arsenous acid decreases expression ISO RGD:1347735 6480464 Arsenic Trioxide results in decreased expression of LGALS1 mRNA, Arsenic Trioxide results in decreased expression of LGALS1 protein CTD PMID:20458559 , PMID:21596116 arsenous acid decreases expression ISO RGD:737568 6480464 Arsenic Trioxide results in decreased expression of LGALS1 protein CTD PMID:21596116 atrazine increases expression ISO RGD:1347735 6480464 Atrazine results in increased expression of LGALS1 mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:1347735 6480464 Benzene results in decreased expression of LGALS1 mRNA CTD PMID:20036648 benzo[a]pyrene multiple interactions ISO RGD:737568 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to LGALS1 promoter] CTD PMID:19654925 benzo[a]pyrene increases methylation ISO RGD:1347735 6480464 Benzo(a)pyrene results in increased methylation of LGALS1 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1347735 6480464 [Soot co-treated with Benzo(a)pyrene] results in increased expression of LGALS1 protein modified form CTD PMID:24464499 benzo[a]pyrene decreases expression ISO RGD:1347735 6480464 Benzo(a)pyrene results in decreased expression of LGALS1 protein CTD PMID:32717239 benzo[a]pyrene increases expression ISO RGD:1347735 6480464 Benzo(a)pyrene results in increased expression of LGALS1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:737568 6480464 Benzo(a)pyrene results in increased expression of LGALS1 mRNA CTD PMID:22228805 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:737568 6480464 Benzo(a)pyrene results in decreased expression of LGALS1 mRNA CTD PMID:19770486 Benzo[k]fluoranthene increases expression ISO RGD:1347735 6480464 benzo(k)fluoranthene results in increased expression of LGALS1 mRNA CTD PMID:22579512 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS1 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide increases expression ISO RGD:737568 6480464 Mustard Gas results in increased expression of LGALS1 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737568 6480464 Diethylhexyl Phthalate results in increased expression of LGALS1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1347735 6480464 Diethylhexyl Phthalate results in increased expression of LGALS1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:737568 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of LGALS1 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO RGD:1347735 6480464 bisphenol A results in decreased expression of LGALS1 mRNA, bisphenol A results in decreased expression of LGALS1 protein CTD PMID:19371625 , PMID:31675489 bisphenol A decreases expression ISO RGD:737568 6480464 bisphenol A results in decreased expression of LGALS1 mRNA CTD PMID:34585602 , PMID:35598803 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS1 mRNA CTD PMID:32145629 bisphenol A increases expression ISO RGD:737568 6480464 bisphenol A results in increased expression of LGALS1 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LGALS1 mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LGALS1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:737568 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LGALS1 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:737568 6480464 bisphenol F results in increased expression of LGALS1 mRNA CTD PMID:30951980 cadmium atom decreases expression ISO RGD:1347735 6480464 Cadmium results in decreased expression of LGALS1 mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO RGD:1347735 6480464 Fulvestrant inhibits the reaction [Cadmium results in decreased expression of LGALS1 mRNA] CTD PMID:31646340 cadmium dichloride decreases expression ISO RGD:1347735 6480464 Cadmium Chloride results in decreased expression of LGALS1 mRNA, Cadmium Chloride results in decreased expression of LGALS1 protein CTD PMID:24419708 , PMID:26472689 cadmium dichloride increases expression ISO RGD:1347735 6480464 Cadmium Chloride results in increased expression of LGALS1 protein CTD PMID:24527689 camptothecin decreases expression ISO RGD:1347735 6480464 Camptothecin results in decreased expression of LGALS1 mRNA, Camptothecin results in decreased expression of LGALS1 protein CTD PMID:19483324 capsaicin increases expression ISO RGD:1347735 6480464 Capsaicin results in increased expression of LGALS1 protein CTD PMID:18991268 carbamazepine affects expression ISO RGD:1347735 6480464 Carbamazepine affects the expression of LGALS1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:737568 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:737568 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin affects expression ISO RGD:1347735 6480464 chloropicrin affects the expression of LGALS1 mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:1347735 6480464 Chlorpyrifos results in decreased expression of LGALS1 mRNA CTD PMID:25424538 choline multiple interactions ISO RGD:737568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LGALS1 gene CTD PMID:20938992 chrysene increases expression ISO RGD:1347735 6480464 chrysene results in increased expression of LGALS1 mRNA CTD PMID:22579512 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of LGALS1 mRNA CTD PMID:22023808 cisplatin decreases response to substance ISO RGD:1347735 6480464 LGALS1 protein results in decreased susceptibility to Cisplatin CTD PMID:30365942 cisplatin multiple interactions ISO RGD:1347735 6480464 3-methyladenine inhibits the reaction [LGALS1 protein results in decreased susceptibility to Cisplatin] more ... CTD PMID:30365942 cisplatin decreases expression ISO RGD:737568 6480464 Cisplatin results in decreased expression of LGALS1 protein CTD PMID:29733421 cisplatin affects expression ISO RGD:1347735 6480464 Cisplatin affects the expression of LGALS1 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:1347735 6480464 Cisplatin results in increased expression of LGALS1 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:737568 6480464 Clobetasol results in increased expression of LGALS1 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:1347735 6480464 cobaltous chloride results in decreased expression of LGALS1 mRNA CTD PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of LGALS1 mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of LGALS1 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of LGALS1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1347735 6480464 Copper Sulfate results in increased expression of LGALS1 mRNA CTD PMID:19549813 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of LGALS1 mRNA CTD PMID:22760963 coumestrol multiple interactions ISO RGD:1347735 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO RGD:1347735 6480464 cupric oxide results in increased expression of LGALS1 protein CTD PMID:25470785 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LGALS1 mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:1347735 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of LGALS1 protein CTD PMID:34122009 cyclophosphamide increases expression ISO RGD:1347735 6480464 Cyclophosphamide results in increased expression of LGALS1 mRNA CTD PMID:17403535 cyclosporin A decreases expression ISO RGD:737568 6480464 Cyclosporine results in decreased expression of LGALS1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1347735 6480464 Cyclosporine results in decreased expression of LGALS1 mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:1347735 6480464 Cyclosporine results in increased expression of LGALS1 mRNA CTD PMID:20106945 , PMID:25562108 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of LGALS1 mRNA CTD PMID:19575532 decabromodiphenyl ether affects expression ISO RGD:1347735 6480464 decabromobiphenyl ether affects the expression of LGALS1 mRNA CTD PMID:24834073 dexamethasone multiple interactions ISO RGD:737568 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LGALS1 mRNA] CTD PMID:16054899 diarsenic trioxide increases response to substance ISO RGD:737568 6480464 LGALS1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:21596116 diarsenic trioxide decreases expression ISO RGD:1347735 6480464 Arsenic Trioxide results in decreased expression of LGALS1 mRNA, Arsenic Trioxide results in decreased expression of LGALS1 protein CTD PMID:20458559 , PMID:21596116 diarsenic trioxide decreases expression ISO RGD:737568 6480464 Arsenic Trioxide results in decreased expression of LGALS1 protein CTD PMID:21596116 diarsenic trioxide decreases secretion ISO RGD:737568 6480464 LGALS1 protein results in decreased secretion of Arsenic Trioxide CTD PMID:21596116 diazinon increases expression ISO RGD:737568 6480464 Diazinon results in increased expression of LGALS1 protein CTD PMID:19647006 dibenz[a,h]anthracene increases expression ISO RGD:1347735 6480464 1 more ... CTD PMID:22579512 dicrotophos decreases expression ISO RGD:1347735 6480464 dicrotophos results in decreased expression of LGALS1 mRNA CTD PMID:28302478 dihydroartemisinin affects binding ISO RGD:1347735 6480464 artenimol analog binds to LGALS1 protein CTD PMID:26340163 dimethyl sulfoxide affects expression ISO RGD:1347735 6480464 Dimethyl Sulfoxide affects the expression of LGALS1 mRNA CTD PMID:24834073 diuron decreases expression ISO RGD:1347735 6480464 Diuron results in decreased expression of LGALS1 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:1347735 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1347735 6480464 Doxorubicin affects the expression of LGALS1 mRNA, Doxorubicin affects the expression of LGALS1 protein CTD PMID:29385562 , PMID:29803840 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of LGALS1 protein CTD PMID:28818578 Enterolactone multiple interactions ISO RGD:1347735 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1347735 6480464 entinostat results in increased expression of LGALS1 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1347735 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LGALS1 protein CTD PMID:23301498 fenamidone increases expression ISO RGD:737568 6480464 fenamidone results in increased expression of LGALS1 mRNA CTD PMID:27029645 fenofibrate increases expression ISO RGD:737568 6480464 Fenofibrate results in increased expression of LGALS1 mRNA CTD PMID:11798191 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of LGALS1 mRNA CTD PMID:34044035 folic acid multiple interactions ISO RGD:737568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LGALS1 gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:1347735 6480464 Formaldehyde results in increased expression of LGALS1 mRNA CTD PMID:18045764 fulvestrant increases expression ISO RGD:1347735 6480464 Fulvestrant results in increased expression of LGALS1 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO RGD:1347735 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of LGALS1 mRNA] more ... CTD PMID:31646340 furan increases expression EXP 6480464 furan results in increased expression of LGALS1 mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:1347735 6480464 Genistein results in decreased expression of LGALS1 mRNA CTD PMID:19371625 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of LGALS1 mRNA CTD PMID:33387578 glycidyl methacrylate increases expression ISO RGD:1347735 6480464 glycidyl methacrylate results in increased expression of LGALS1 protein CTD PMID:36641056 haloperidol multiple interactions ISO RGD:1347735 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of LGALS1 protein CTD PMID:34122009 hyaluronic acid increases expression EXP 6480464 Hyaluronic Acid analog results in increased expression of LGALS1 protein CTD PMID:23178681 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide results in decreased expression of LGALS1 protein] CTD PMID:23178681 hydralazine multiple interactions ISO RGD:1347735 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS1 mRNA CTD PMID:17183730 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide results in decreased expression of LGALS1 protein] CTD PMID:23178681 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of LGALS1 protein CTD PMID:23178681 ibuprofen affects expression ISO RGD:1347735 6480464 Ibuprofen affects the expression of LGALS1 protein CTD PMID:18351690 imidazopyrazole increases expression ISO RGD:1347735 6480464 imidazopyrazole analog results in increased expression of LGALS1 mRNA CTD PMID:30388846 Indeno[1,2,3-cd]pyrene increases expression ISO RGD:1347735 6480464 indeno(1 more ... CTD PMID:22579512 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of LGALS1 mRNA CTD PMID:21396975 inulin multiple interactions ISO RGD:737568 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of LGALS1 mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:1347735 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LGALS1 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1347735 6480464 Ivermectin results in decreased expression of LGALS1 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:1347735 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of LGALS1 mRNA CTD PMID:17639512 L-methionine multiple interactions ISO RGD:737568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LGALS1 gene CTD PMID:20938992 lead(0) affects expression ISO RGD:1347735 6480464 Lead affects the expression of LGALS1 mRNA CTD PMID:28903495 lidocaine decreases expression ISO RGD:737568 6480464 Lidocaine results in decreased expression of LGALS1 protein CTD PMID:18382663 lipopolysaccharide increases expression ISO RGD:737568 6480464 Lipopolysaccharides results in increased expression of LGALS1 mRNA CTD PMID:27339419 malathion decreases expression ISO RGD:1347735 6480464 Malathion results in decreased expression of LGALS1 mRNA CTD PMID:32069766 microcystin RR decreases expression ISO RGD:1347735 6480464 microcystin RR results in decreased expression of LGALS1 protein CTD PMID:19111056 microcystin-LR increases expression ISO RGD:737568 6480464 cyanoginosin LR results in increased expression of LGALS1 mRNA CTD PMID:17654400 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:737568 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of LGALS1 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of LGALS1 mRNA CTD PMID:16026605 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LGALS1 mRNA CTD PMID:18164116 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LGALS1 mRNA CTD PMID:25380136 N-nitrosodimethylamine increases expression ISO RGD:1347735 6480464 Dimethylnitrosamine results in increased expression of LGALS1 mRNA CTD PMID:17547211 naphthalene increases expression ISO RGD:737568 6480464 naphthalene results in increased expression of LGALS1 mRNA CTD PMID:18978301 naphthalene increases expression ISO RGD:1347735 6480464 naphthalene results in increased expression of LGALS1 mRNA CTD PMID:22579512 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of LGALS1 mRNA CTD PMID:21086188 nicotine increases expression ISO RGD:1347735 6480464 Nicotine results in increased expression of LGALS1 mRNA CTD PMID:23825647 ouabain affects expression ISO RGD:1347735 6480464 Ouabain affects the expression of LGALS1 protein CTD PMID:17268060 ouabain increases expression ISO RGD:1347735 6480464 Ouabain results in increased expression of LGALS1 protein CTD PMID:18247327 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LGALS1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:737568 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LGALS1 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:1347735 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS1 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:737568 6480464 Acetaminophen affects the expression of LGALS1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LGALS1 mRNA CTD PMID:33387578 parathion decreases expression ISO RGD:737568 6480464 Parathion results in decreased expression of LGALS1 mRNA CTD PMID:34813904 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:737568 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS1 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1347735 6480464 perfluorooctanoic acid results in increased expression of LGALS1 protein CTD PMID:26879310 phenanthrene increases expression ISO RGD:1347735 6480464 phenanthrene results in increased expression of LGALS1 mRNA CTD PMID:22579512 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LGALS1 mRNA CTD PMID:30047161 phenylmercury acetate decreases expression ISO RGD:1347735 6480464 Phenylmercuric Acetate results in decreased expression of LGALS1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347735 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LGALS1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:737568 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:737568 6480464 pirinixic acid results in increased expression of LGALS1 mRNA CTD PMID:11798191 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of LGALS1 mRNA CTD PMID:19162173 progesterone affects metabolic processing ISO RGD:737568 6480464 LGALS1 protein affects the metabolism of Progesterone CTD PMID:17242467 quercetin multiple interactions ISO RGD:1347735 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of LGALS1 mRNA CTD PMID:17639512 quercetin increases expression ISO RGD:1347735 6480464 Quercetin results in increased expression of LGALS1 mRNA CTD PMID:21632981 reactive oxygen species increases abundance ISO RGD:1347735 6480464 LGALS1 protein modified form results in increased abundance of Reactive Oxygen Species CTD PMID:20695460 reactive oxygen species multiple interactions ISO RGD:1347735 6480464 [LGALS1 protein binds to Naphthoquinones] which results in increased abundance of Reactive Oxygen Species CTD PMID:20695460 resveratrol decreases expression ISO RGD:1347735 6480464 resveratrol results in decreased expression of LGALS1 mRNA CTD PMID:19371625 resveratrol affects secretion ISO RGD:1347735 6480464 resveratrol affects the secretion of LGALS1 protein CTD PMID:24802182 SB 431542 multiple interactions ISO RGD:1347735 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:737568 6480464 Silicon Dioxide results in increased expression of LGALS1 mRNA CTD PMID:29341224 sodium arsenite decreases expression ISO RGD:1347735 6480464 sodium arsenite results in decreased expression of LGALS1 protein CTD PMID:21596116 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of LGALS1 protein CTD PMID:29459688 sodium arsenite decreases expression ISO RGD:737568 6480464 sodium arsenite results in decreased expression of LGALS1 protein CTD PMID:21596116 sodium arsenite increases response to substance ISO RGD:737568 6480464 LGALS1 protein results in increased susceptibility to sodium arsenite CTD PMID:21596116 sodium arsenite decreases secretion ISO RGD:737568 6480464 LGALS1 protein results in decreased secretion of sodium arsenite CTD PMID:21596116 sodium dichromate decreases expression ISO RGD:1347735 6480464 sodium bichromate results in decreased expression of LGALS1 mRNA CTD PMID:17685462 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LGALS1 mRNA, sodium bichromate results in increased expression of LGALS1 protein CTD PMID:21437922 sodium fluoride increases expression ISO RGD:737568 6480464 Sodium Fluoride results in increased expression of LGALS1 protein CTD PMID:27548804 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of LGALS1 mRNA CTD PMID:30047161 sulforaphane affects binding ISO RGD:1347735 6480464 LGALS1 protein binds to sulforaphane CTD PMID:21838287 sulforaphane decreases expression ISO RGD:1347735 6480464 sulforaphane results in decreased expression of LGALS1 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1347735 6480464 Sunitinib results in decreased expression of LGALS1 mRNA CTD PMID:31533062 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of LGALS1 protein CTD PMID:26141394 tamibarotene increases expression ISO RGD:1347735 6480464 tamibarotene results in increased expression of LGALS1 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:737568 6480464 Tamoxifen affects the expression of LGALS1 mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1347735 6480464 Temozolomide results in decreased expression of LGALS1 mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:737568 6480464 Carbon Tetrachloride results in increased expression of LGALS1 mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LGALS1 mRNA CTD PMID:33387578 tetrachloromethane affects expression ISO RGD:737568 6480464 Carbon Tetrachloride affects the expression of LGALS1 mRNA CTD PMID:31919559 tetradecane decreases expression EXP 6480464 n-tetradecane results in decreased expression of LGALS1 protein CTD PMID:17337753 tetraphene increases expression ISO RGD:1347735 6480464 benz(a)anthracene results in increased expression of LGALS1 mRNA CTD PMID:22579512 thapsigargin decreases expression ISO RGD:1347735 6480464 Thapsigargin results in decreased expression of LGALS1 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LGALS1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:737568 6480464 titanium dioxide results in increased expression of LGALS1 mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LGALS1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1347735 6480464 trichostatin A results in increased expression of LGALS1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1347735 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS1 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1347735 6480464 Triclosan results in increased expression of LGALS1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:737568 6480464 trimellitic anhydride results in increased expression of LGALS1 mRNA CTD PMID:19042947 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1347735 6480464 tris(2-butoxyethyl) phosphate affects the expression of LGALS1 mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:737568 6480464 troglitazone results in increased expression of LGALS1 mRNA CTD PMID:28973697 tungsten increases expression ISO RGD:737568 6480464 Tungsten results in increased expression of LGALS1 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO RGD:1347735 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS1 mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of LGALS1 mRNA CTD PMID:34779009 valproic acid increases expression ISO RGD:1347735 6480464 Valproic Acid results in increased expression of LGALS1 mRNA CTD PMID:19101580 more ... valproic acid increases expression ISO RGD:737568 6480464 Valproic Acid results in increased expression of LGALS1 mRNA CTD PMID:15345369 more ... valproic acid increases methylation ISO RGD:1347735 6480464 Valproic Acid results in increased methylation of LGALS1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1347735 6480464 Valproic Acid affects the expression of LGALS1 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:737568 6480464 Vancomycin results in decreased expression of LGALS1 mRNA CTD PMID:18930951 vorinostat increases expression ISO RGD:1347735 6480464 vorinostat results in increased expression of LGALS1 mRNA CTD PMID:27188386 zearalenone decreases expression ISO RGD:1347735 6480464 Zearalenone results in decreased expression of LGALS1 mRNA CTD PMID:19371625 zidovudine multiple interactions ISO RGD:1347735 6480464 [Zidovudine co-treated with IFNA1 protein] results in decreased expression of LGALS1 mRNA CTD PMID:20370541 zinc oxide decreases expression EXP 6480464 Zinc Oxide results in decreased expression of LGALS1 protein CTD PMID:33205376